Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/2010
04/01/2010US20100081810 C-Pyrazole A2A Receptor Agonists
04/01/2010US20100081697 Crystalline freebase of 4'-{2-ethoxy-4-ethyl-5-[((S)-2-mercapto-4-methylpentanoylamino)methyl]imidazol-1-ylmethyl}-3'-fluorobiphenyl-2-carboxylic acid; stability; high melting point; nondeliquescent; hypotensive agents; heart failure; angiotensin II type 1 receptor antagonist; enkephalinase inhibitor
04/01/2010US20100081671 Cycloalkylamine substituted isoquinoline derivatives
04/01/2010US20100081670 N-pyrazinyl-phenylsulphonamides and their use in the treatment of chemokine mediated diseases
04/01/2010US20100081652 Cinnamoyl Compound and Use Thereof
04/01/2010US20100081645 Tricyclic heteroaryl compounds useful as inhibitors of janus kinase
04/01/2010US20100081643 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents
04/01/2010US20100081639 Pharmaceutical composition comprising fermented ginseng
04/01/2010US20100080846 Dipyridamole and acetylsalicylic acid formulations and process for preparing same
04/01/2010US20100080810 Methods of treating diseases with anti-vegf antibodies
04/01/2010CA2738285A1 Method for producing lipids
04/01/2010CA2738282A1 Method for concentrating lipids
04/01/2010CA2738147A1 Solid pharmaceutical composition
04/01/2010CA2737739A1 Heteroaryl antagonists of prostaglandin d2 receptors
03/2010
03/31/2010EP2169059A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis
03/31/2010EP2169038A1 A process for decreasing environmental pollutants in an oil or a fat, and a fish feed product
03/31/2010EP2168984A1 Human antibodies that bind human IL-12 and methods for producing
03/31/2010EP2168969A2 Racemization and Enantiomer Separation of Clopidogrel
03/31/2010EP2168960A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168959A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient
03/31/2010EP2168958A1 Isoindole-Imide Compounds, Compositions And Uses Thereof
03/31/2010EP2168952A1 Morpholine derivative
03/31/2010EP2168600A1 Therapeutic or prophylactic agent for cerebral aneurysm
03/31/2010EP2168581A2 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
03/31/2010EP2168576A2 New utilities of tricyclic compounds
03/31/2010EP2167482A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
03/31/2010EP2167472A2 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
03/31/2010EP2167113A2 Neuroplastin derived peptides
03/31/2010EP2167109A2 Material compositions which comprise adult stem cells obtained from exocrine glandular tissue, in particular for use in regenerative medicine, e.g. for restoring injured or damaged myocardial tissue
03/31/2010EP2167099A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
03/31/2010EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors
03/31/2010EP2167070A1 Use of nitric oxide releasing compounds in the treatment of chronic pain
03/31/2010EP2166847A1 Cetp inhibitors derived from benzoxazole arylamides
03/31/2010EP1786814B1 Bicyclononene derivatives as renin inhibitors
03/31/2010EP1758596B1 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
03/31/2010EP1244460B1 Use of dipyridinium compounds for treating a disease characterized by proliferating cells containing nitric oxide synthase
03/31/2010CN101688178A Stem cell-derived retinal pigment epithelial cells
03/31/2010CN101687916A Inflammation treatment, detection and monitoring via trem-1
03/31/2010CN101687875A Pyrrolopyrimidin-7-one derivatives and their use as pharmaceuticals
03/31/2010CN101687873A Fused heterocyclic 11-beta-hydroxysteroid dehydrogenase type i inhibitors
03/31/2010CN101687869A Heterocyclic compounds useful as MK2 inhibitors
03/31/2010CN101687855A Phthalazinone derivatives and their use as medicament to treat cancer
03/31/2010CN101687850A Substituted pyrimidines as adenosine receptor antagonists
03/31/2010CN101687847A N5-(2-ethoxyethyl)-N3-(2-pyridinyl) -3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
03/31/2010CN101687844A Imidazole derivatives as CCR2 receptor antagonists
03/31/2010CN101687807A 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
03/31/2010CN101687805A Benzazepine derivatives useful as vasopressin antagonists
03/31/2010CN101687047A Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
03/31/2010CN101687032A Antagonist antibodies against ephb3
03/31/2010CN101687014A compositions and methods for treating pathologic angiogenesis and vascular permeability
03/31/2010CN101687008A Therapeutic agent and detection reagent for arteriosclerotic disease which targets for thallusin
03/31/2010CN101686970A Synergistic combination of anthranilamide pyridinureas and benzamide derivatives
03/31/2010CN101686959A Combination therapy with a compound acting as a platelet ADP receptor inhibitor
03/31/2010CN101686953A Use of 4-(nitrooxy)-butyl-(s)-2-(6-methoxy-2-naphtyl)-propanoate for treating pain and inflammation
03/31/2010CN101686919A Use of citrulline for the treatment of conditions linked to an increase in protein carbonylation
03/31/2010CN101686724A Kit of nutritional compositions for infants with fat and carbohydrate content adapted to the particular stage of development
03/31/2010CN101684099A Propionic acid derivative of substituted aromatic ring and aromatic heterocycle and preparation method and application thereof
03/31/2010CN101684098A 5-lipoxygenase inhibitor and preparation method, medical composite and application thereof
03/31/2010CN101684091A cannabinoid receptor ligands
03/31/2010CN101683533A Gene transfer-mediated angiogenesis therapy
03/31/2010CN101683531A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683530A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683529A Novel ppar ligands that do not cause fluid retention, edema or congestive heart failure
03/31/2010CN101683526A Pharmaceutical composition containing angiotensin II receptor antagonist, B vitamins and gingo biloba extract
03/31/2010CN101683508A Capsule for strengthening heart and boosting pressure
03/31/2010CN101683507A Traditional Chinese medicine composition for supplementing qi and invigorating blood circulation
03/31/2010CN101683506A Traditional Chinese medicine composition for treating hemorrhoids
03/31/2010CN101683504A Preparation method of relieved pill for activating blood circulation to dissipate blood stasis
03/31/2010CN101683503A Traditional Chinese medicine composition for nourishing heart and strengthening heart
03/31/2010CN101683502A Chinese medicinal composition for promoting blood circulation, benefiting qi and strengthening brain
03/31/2010CN101683493A Traditional Chinese medicine composition for cerebral hemorrhage
03/31/2010CN101683491A Traditional Chinese medicine composition with function of promoting lactation and removing collaterals
03/31/2010CN101683478A Traditional Chinese medicine composition for thrombolysis
03/31/2010CN101683475A Prescription capable of comprehensively repairing cardio-cerebrovascular cycle system and preparation method
03/31/2010CN101683471A Traditional Chinese medicine composition with function of brain tonic and vein relaxing
03/31/2010CN101683465A Preparation method of flavored pill for tranquilizing mind and calming heart
03/31/2010CN101683463A Traditional Chinese medicine composition for nourishing yin and recovering vein
03/31/2010CN101683458A Application of a traditional Chinese medicine composition in preparation of medicament for treating vertigo
03/31/2010CN101683456A Traditional Chinese medicine composition for suppressing hyperactive liver, tranquilizing endogenous wind, eliminating phlegm and removing blood stasis
03/31/2010CN101683455A Traditional Chinese medicine composition for bowel lavage
03/31/2010CN101683449A Preparation method of ointment containing lotus and mulberry
03/31/2010CN101683443A Chinese medicinal composition for resolving stasis and strengthening heart
03/31/2010CN101683441A Traditional Chinese medicine composition for invigorating blood circulation and dissolving stasis
03/31/2010CN101683430A Traditional Chinese medicine composition for treating lacunar infarction
03/31/2010CN101683428A Traditional Chinese medicine composition with function of gore removing and vein relaxing
03/31/2010CN101683419A Traditional Chinese medicine composition for cooling the blood and stopping the blood
03/31/2010CN101683418A Preparation method of navel applying ointment for reducing blood pressure
03/31/2010CN101683417A Traditional Chinese medicine composition with function of warming yang and gore removing
03/31/2010CN101683416A Natural composition for prevention and control of cardiovascular and cerebrovascular diseases, preparation method and uses thereof
03/31/2010CN101683406A Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension
03/31/2010CN101683405A Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing brain stroke
03/31/2010CN101683394A Externally applied patch for treating phlebitis and method for producing the same
03/31/2010CN101683387A Medication and preparation method and application thereof
03/31/2010CN101683386A Formula of Chinese medicinal liquor having function of reducing blood pressure and preparation method thereof
03/31/2010CN101683368A medicinal composition for anti-stroke and anti-sequelae thereof, improving heart cerebral ischemia, preparation process and preparation thereof
03/31/2010CN101683363A Composition preparation of ginkgo biloba extract and dipyridamole and preparation method thereof
03/31/2010CN101683360A Extraction and purifying technology of propolis flavones and anticancer mechanism thereof
03/31/2010CN101683348A Application of cholestane-3 beta, 5 alpha, 6 beta-triol in preparation of neuronal protection medicine
03/31/2010CN101683343A Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury
03/31/2010CN101683338A Application of hirsutine in preparing medicament for treating myocardial damage